Buprenorphine implant for opioid addiction.

Abstract

SUMMARY The buprenorphine implant (Probuphine™, Titan Pharmaceuticals, CA, USA) is a recently developed long-acting formulation of buprenorphine, which is a partial opioid agonist that is widely used in the marketed, sublingual, daily-dose form for managing opioid addiction. The new formulation uses a novel delivery system consisting of subcutaneously… (More)
DOI: 10.2217/pmt.12.26

Topics

  • Presentations referencing similar topics